{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:54:35Z","timestamp":1791114875880,"version":"4.1.0"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,3,1]]},"DOI":"10.1093\/ndt\/gfi181","type":"journal-article","created":{"date-parts":[[2005,10,12]],"date-time":"2005-10-12T20:13:01Z","timestamp":1129147981000},"page":"598-604","source":"Crossref","is-referenced-by-count":240,"title":["Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD)"],"prefix":"10.1093","volume":"21","author":[{"given":"Patricia R.","family":"Wahl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas L.","family":"Serra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Le Hir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus D.","family":"Molle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael N.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf P.","family":"W\u00fcthrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2005,10,11]]},"reference":[{"key":"key\n\t\t\t\t20171012191835_BIB1","doi-asserted-by":"crossref","unstructured":"Wilson PD. Polycystic kidney disease. N Engl J Med2004; 350: 151\u2013164","DOI":"10.1056\/NEJMra022161"},{"key":"key\n\t\t\t\t20171012191835_BIB2","doi-asserted-by":"crossref","unstructured":"Igarashi P, Somlo S. Genetics and pathogenesis of polycystic kidney disease. J Am Soc Nephrol2002; 13: 2384\u20132398","DOI":"10.1097\/01.ASN.0000028643.17901.42"},{"key":"key\n\t\t\t\t20171012191835_BIB3","doi-asserted-by":"crossref","unstructured":"Harris PC. Molecular basis of polycystic kidney disease: PKD1, PKD2 and PKHD1. Curr Opin Nephrol Hypertens2002; 11: 309\u2013314","DOI":"10.1097\/00041552-200205000-00007"},{"key":"key\n\t\t\t\t20171012191835_BIB4","doi-asserted-by":"crossref","unstructured":"The European Polycystic Kidney Disease Consortium. The polycystic kidney disease 1 gene encodes a 14\u2009kb transcript and lies within a duplicated region on chromosome 16. Cell1994; 77: 881\u2013894","DOI":"10.1016\/0092-8674(94)90137-6"},{"key":"key\n\t\t\t\t20171012191835_BIB5","doi-asserted-by":"crossref","unstructured":"The International Polycystic Kidney Disease Consortium. Polycystic kidney disease: the complete structure of the PKD1 gene and its protein. Cell1995; 81: 289\u2013298","DOI":"10.1016\/0092-8674(95)90339-9"},{"key":"key\n\t\t\t\t20171012191835_BIB6","doi-asserted-by":"crossref","unstructured":"Mochizuki T, Wu G, Hayashi T et al. PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science1996; 272: 1339\u20131342","DOI":"10.1126\/science.272.5266.1339"},{"key":"key\n\t\t\t\t20171012191835_BIB7","doi-asserted-by":"crossref","unstructured":"Delmas P. Polycystins: from mechanosensation to gene regulation. Cell2004; 118: 145\u2013148","DOI":"10.1016\/j.cell.2004.07.007"},{"key":"key\n\t\t\t\t20171012191835_BIB8","doi-asserted-by":"crossref","unstructured":"Torres VE, Sweeney WE Jr, Wang X et al. Epidermal growth factor receptor tyrosine kinase inhibition is not protective in PCK rats. Kidney Int2004; 66: 1766\u20131773","DOI":"10.1111\/j.1523-1755.2004.00952.x"},{"key":"key\n\t\t\t\t20171012191835_BIB9","doi-asserted-by":"crossref","unstructured":"Torres VE. Therapies to slow polycystic kidney disease. Nephron Exp Nephrol2004; 98: e1\u2013e7","DOI":"10.1159\/000079926"},{"key":"key\n\t\t\t\t20171012191835_BIB10","doi-asserted-by":"crossref","unstructured":"Wang X, Gattone V 2nd, Harris PC, Torres VE. Effectiveness of vasopressin V2 receptor antagonists OPC-31260 and OPC-41061 on polycystic kidney disease development in the PCK rat. J Am Soc Nephrol2005; 16: 846\u2013851","DOI":"10.1681\/ASN.2004121090"},{"key":"key\n\t\t\t\t20171012191835_BIB11","doi-asserted-by":"crossref","unstructured":"Gretz N, Kranzlin B, Pey R et al. Rat models of autosomal dominant polycystic kidney disease. Nephrol Dial Transplant1996; 11 [Suppl 6]: 46\u201351","DOI":"10.1093\/ndt\/11.supp6.46"},{"key":"key\n\t\t\t\t20171012191835_BIB12","doi-asserted-by":"crossref","unstructured":"Tao Y, Kim J, Schrier RW, Edelstein CL. Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease. J Am Soc Nephrol2005; 16: 46\u201351","DOI":"10.1681\/ASN.2004080660"},{"key":"key\n\t\t\t\t20171012191835_BIB13","doi-asserted-by":"crossref","unstructured":"Guba M, von Breitenbuch P, Steinbauer M et al. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nat Med2002; 8: 128\u2013135","DOI":"10.1038\/nm0202-128"},{"key":"key\n\t\t\t\t20171012191835_BIB14","doi-asserted-by":"crossref","unstructured":"Schmelzle T, Hall MN. TOR, a central controller of cell growth. Cell2000; 103: 253\u2013262","DOI":"10.1016\/S0092-8674(00)00117-3"},{"key":"key\n\t\t\t\t20171012191835_BIB15","doi-asserted-by":"crossref","unstructured":"Moses JW, Leon MB, Popma JJ et al. Sirolimus-elut stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med2003; 349: 1315\u20131323","DOI":"10.1056\/NEJMoa035071"},{"key":"key\n\t\t\t\t20171012191835_BIB16","doi-asserted-by":"crossref","unstructured":"Stallone G, Schena A, Infante B et al. Sirolimus for Kaposi's sarcoma in renal-transplant recipients. N Engl J Med2005; 352: 1317\u20131323","DOI":"10.1056\/NEJMoa042831"},{"key":"key\n\t\t\t\t20171012191835_BIB17","doi-asserted-by":"crossref","unstructured":"Lieberthal W, Fuhro R, Andry CC et al. Rapamycin impairs recovery from acute renal failure: role of cell-cycle arrest and apoptosis of tubular cells. Am J Physiol Renal Physiol2001; 281: F693\u2013F706","DOI":"10.1152\/ajprenal.2001.281.4.F693"},{"key":"key\n\t\t\t\t20171012191835_BIB18","doi-asserted-by":"crossref","unstructured":"Mathieu O, Cruz-Orive LM, Hoppeler H, Weibel ER. Measuring error and sampling variation in stereology: comparison of the efficiency of various methods for planar image analysis. J Microsc1981; 121: 75\u201388","DOI":"10.1111\/j.1365-2818.1981.tb01200.x"},{"key":"key\n\t\t\t\t20171012191835_BIB19","doi-asserted-by":"crossref","unstructured":"Inoki K, Corradetti MN, Guan KL. Dysregulation of the TSC-mTOR pathway in human disease. Nat Genet2005; 37: 19\u201324","DOI":"10.1038\/ng1494"},{"key":"key\n\t\t\t\t20171012191835_BIB20","doi-asserted-by":"crossref","unstructured":"Pearson RB, Dennis PB, Han JW et al. The principal target of rapamycin-induced p70S6K inactivation is a novel phosphorylation site within a conserved hydrophobic domain. Embo J1995; 14: 5279\u20135287","DOI":"10.1002\/j.1460-2075.1995.tb00212.x"},{"key":"key\n\t\t\t\t20171012191835_BIB21","doi-asserted-by":"crossref","unstructured":"Khaleghpour K, Pyronnet S, Gingras AC, Sonenberg N. Translational homeostasis: eukaryotic translation initiation factor 4E control of 4E-binding protein 1 and p70 S6 kinase activities. Mol Cell Biol1999; 19: 4302\u20134310","DOI":"10.1128\/MCB.19.6.4302"},{"key":"key\n\t\t\t\t20171012191835_BIB22","doi-asserted-by":"crossref","unstructured":"Isotani S, Hara K, Tokunaga C, Inoue H, Avruch J, Yonezawa K. Immunopurified mammalian target of rapamycin phosphorylates and activates p70 S6 kinase alpha in vitro. J Biol Chem1999; 274: 34493\u201334498","DOI":"10.1074\/jbc.274.48.34493"},{"key":"key\n\t\t\t\t20171012191835_BIB23","doi-asserted-by":"crossref","unstructured":"Saitoh M, Pullen N, Brennan P, Cantrell D, Dennis PB, Thomas G. Regulation of an activated S6 kinase 1 variant reveals a novel mammalian target of rapamycin phosphorylation site. J Biol Chem2002; 277: 20104\u201320112","DOI":"10.1074\/jbc.M201745200"},{"key":"key\n\t\t\t\t20171012191835_BIB24","doi-asserted-by":"crossref","unstructured":"Hay N, Sonenberg N. Upstream and downstream of mTOR. Genes Dev2004; 18: 1926\u20131945","DOI":"10.1101\/gad.1212704"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/21\/3\/598\/6900509\/gfi181.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,30]],"date-time":"2019-03-30T19:11:18Z","timestamp":1553973078000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/ndt\/article\/21\/3\/598\/1854456\/Inhibition-of-mTOR-with-sirolimus-slows-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10,11]]},"references-count":24,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2005,10,11]]},"published-print":{"date-parts":[[2006,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfi181","relation":{},"ISSN":["1460-2385","0931-0509"],"issn-type":[{"value":"1460-2385","type":"electronic"},{"value":"0931-0509","type":"print"}],"subject":[],"published-other":{"date-parts":[[2006,3]]},"published":{"date-parts":[[2005,10,11]]}}}